Loiacono Michael 4
4 · Marker Therapeutics, Inc. · Filed Oct 23, 2018
Insider Transaction Report
Form 4
Loiacono Michael
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2018-10-19+300,000→ 300,000 totalExercise: $9.18Exp: 2028-10-19→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]Represents options granted under the Company's 2014 Omnibus Stock Ownership Plan, as amended. These shares vest in monthly installments over a four year period upon the continued employment of the Reporting Person by the Company through the vesting dates. The option exercise price is the closing price on the date of the grant, October 19, 2018.